© 2021 MJH Life Sciences and HCPLive - Clinical news for connected physicians. All rights reserved.
© 2021 MJH Life Sciences™ and HCPLive - Clinical news for connected physicians. All rights reserved.
The HCPLive ADHD condition center page is a comprehensive resource for clinical news and insights on ADHD. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for ADHD.
February 12, 2021
Researchers find an increased risk of offspring ADHD symptoms due to maternal anxiety.
February 09, 2021
Researchers found a significant association between polygenic risk scores for ADHD and reaction time variability, but not commission errors.
February 08, 2021
Recent clinical trials have shown positive topline results for SPN-812.
February 03, 2021
Dr. Cortese explains how more data could improve ADHD care.
February 02, 2021
Dr. Cortese discusses the current gaps in ADHD treatment.
January 19, 2021
Dr. Matthew Brams presented new data showing the efficacy of CTx-1301 for ADHD.
January 18, 2021
CTx-1301's formulation enables 3 different doses within 1 pill for ADHD.
Researchers are prepared a phase 3 trial testing the treatment in adults with ADHD.
The role of many in psychiatry has changed during the COVID-19 pandemic.
Such scores could provide insight into the significant comorbidity rate of ADHD and other youth mood and emotional dysregulation issues.